PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

A Sphingosine-1-Phosphate Receptor Modulator Attenuated Secondary Brain Injury and Improved Neurological Functions of Mice after ICH

Mouse / Haemorrhage/shock

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32963692 ↗2020Reported benefit

A Sphingosine-1-Phosphate Receptor Modulator Attenuated Secondary Brain Injury and Improved Neurological Functions of Mice after ICH

MouseHaemorrhage/shockUnspecifiedC57BL/6Nn = 134 mice total, divided into sham and ICH groups with treat…Intraperitoneal0.3 mg/kg (low dose) or 3.0 mg/kg (high dose) in 0.5% DMSOFirst dose 30 minutes post-ICH

Model: Collagenase-induced intracerebral haemorrhage (ICH)

Low-dose Siponimod, particularly with multiple administrations, significantly reduced ICH-induced brain oedema at 72 hours, attenuated ventriculomegaly at 10 days, improved neurological motor function and working memory, and reduced CD3+ lymphocyte brain infiltration; high-dose Siponimod was ineffe…

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.